CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 212 enrolled
Drug / intervention
T-CAT topography-guided LASIK treatment with the Allegretto Wave Eye-Q 400 Hz Excimer Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01028378
NCT01028378Phase 3Completed
CompareCT.gov

Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors

Clinical Research Consultants, Inc.·interventional·Posted Dec 9, 2009·Updated Apr 11, 2016

In Brief

A Phase 3 clinical trial evaluating T-CAT topography-guided LASIK treatment with the Allegretto Wave Eye-Q 400 Hz Excimer Laser for Myopia and Hyperopia. Completed, enrolled 212 participants across 10 sites.

Detailed Summary

This purpose of this study is to evaluate the safety and effectiveness of a topography-based custom ablation treatment using the ALLEGRETTO WAVE® Eye-Q 400 Hz laser system for treating myopia and hyperopia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia
CountriesUnited States
CollaboratorsAlcon Research, WaveLight AG

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 9, 2009
Enrollment StartOct 1, 2009
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 16.6 years ago

Interventions

T-CAT topography-guided LASIK treatment with the Allegretto Wave Eye-Q 400 Hz Excimer Laserdevice